Hippo Pathway Activity Influences Liver Cell Fate

The Hippo-signaling pathway is an important regulator of cellular proliferation and organ size. However, little is known about the role of this cascade in the control of cell fate. Employing a combination of lineage tracing, clonal analysis, and organoid culture approaches, we demonstrate that Hippo pathway activity is essential for the maintenance of the differentiated hepatocyte state. Remarkably, acute inactivation of Hippo pathway signaling in vivo is sufficient to dedifferentiate, at very high efficiencies, adult hepatocytes into cells bearing progenitor characteristics. These hepatocyte-derived progenitor cells demonstrate self-renewal and engraftment capacity at the single-cell level. We also identify the NOTCH-signaling pathway as a functional important effector downstream of the Hippo transducer YAP. Our findings uncover a potent role for Hippo/YAP signaling in controlling liver cell fate and reveal an unprecedented level of phenotypic plasticity in mature hepatocytes, which has implications for the understanding and manipulation of liver regeneration.

[1]  R. Wells,et al.  Robust cellular reprogramming occurs spontaneously during liver regeneration. , 2013, Genes & development.

[2]  G. Michalopoulos,et al.  Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes. , 1996, The American journal of pathology.

[3]  P. Mazur,et al.  Liver‐specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice , 2008, Hepatology.

[4]  Shian Wu,et al.  The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. , 2008, Developmental cell.

[5]  Hans Clevers,et al.  In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration , 2013, Nature.

[6]  G. Weinmaster,et al.  Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome , 2010, Development.

[7]  M. Oertel,et al.  Stem cells, cell transplantation and liver repopulation. , 2008, Biochimica et biophysica acta.

[8]  M. Manns,et al.  A critical role for notch signaling in the formation of cholangiocellular carcinomas. , 2013, Cancer cell.

[9]  Sayaka Sekiya,et al.  Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. , 2012, The Journal of clinical investigation.

[10]  I. Leclercq,et al.  Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. , 2012, Gastroenterology.

[11]  B. Trump,et al.  Mouse liver cell culture , 1981, In Vitro.

[12]  G. Michalopoulos.  Phenotypic fidelity (or not?) of epithelial cells in the liver , 2012, Hepatology.

[13]  G. Darlington,et al.  Elevated interferon gamma signaling contributes to impaired regeneration in the aged liver. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  Thomas Gridley,et al.  A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. , 2002, Development.

[15]  G. Gores,et al.  Cholangiocarcinomas can originate from hepatocytes in mice. , 2012, The Journal of clinical investigation.

[16]  M. Sudol,et al.  Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)* , 2008, Journal of Biological Chemistry.

[17]  R. Jaenisch,et al.  YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells , 2007, Current Biology.

[18]  Hammad Qureshi.  Contributions , 1974, Livre Blanc de la Recherche en Mécanique.

[19]  G. Michalopoulos,et al.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury , 2005, Hepatology.

[20]  Jiandie D. Lin,et al.  TEAD mediates YAP-dependent gene induction and growth control. , 2008, Genes & development.

[21]  Frank Bergmann,et al.  Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. , 2013, Gastroenterology.

[22]  A. Bell,et al.  Expression of Notch‐1 and its ligand Jagged‐1 in rat liver during liver regeneration , 2004, Hepatology.

[23]  D. Rader,et al.  Expression of Cholesteryl Ester Transfer Protein in Mice Promotes Macrophage Reverse Cholesterol Transport , 2007, Circulation.

[24]  T. Honjo,et al.  Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. , 2002, International immunology.

[25]  Adrian E. Raftery,et al.  Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .

[26]  G. G. Galli,et al.  Prdm5 Regulates Collagen Gene Transcription by Association with RNA Polymerase II in Developing Bone , 2012, PLoS genetics.

[27]  U. Apte,et al.  Deregulation of Hippo kinase signalling in Human hepatic malignancies , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[28]  J. Schug,et al.  Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. , 2011, Genes & development.

[29]  M. Kay,et al.  Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. , 2011, The Journal of clinical investigation.

[30]  Barry Behr,et al.  Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitment , 2012, Proceedings of the National Academy of Sciences.

[31]  Yunfang Wang,et al.  Human hepatic stem cell and maturational liver lineage biology , 2011, Hepatology.

[32]  T. Roskams,et al.  Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes , 2012, Hepatology.

[33]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[34]  M. Giovannini,et al.  Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. , 2010, Genes & development.

[35]  B. Stanger,et al.  Notch signaling controls liver development by regulating biliary differentiation , 2009, Development.

[36]  L. Greenbaum.  The ductal plate: a source of progenitors and hepatocytes in the adult liver. , 2011, Gastroenterology.

[37]  S. Lindstedt,et al.  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I , 1995, Nature Genetics.

[38]  G. Halder,et al.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis , 2006, Nature Cell Biology.

[39]  D. Calvisi,et al.  The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[40]  V. Factor,et al.  Common antigen of oval and biliary epithelial cells (A6) is a differentiation marker of epithelial and erythroid cell lineages in early development of the mouse. , 1993, Differentiation; research in biological diversity.

[41]  J. Deng,et al.  Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine , 2011, Nature Genetics.

[42]  M. Giovannini,et al.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. , 2010, Developmental cell.

[43]  G. Feldmann,et al.  Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals , 2007, Cell.

[44]  Ju-Seog Lee,et al.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver , 2010, Proceedings of the National Academy of Sciences.

[45]  A. Means,et al.  A CK19CreERT knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs , 2008, Genesis.

[46]  F. Camargo,et al.  The Hippo signaling pathway and stem cell biology. , 2012, Trends in cell biology.

[47]  B. Wang,et al.  The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. , 2008, Developmental cell.

[48]  Kwok-Kin Wong,et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway , 2013, Nature Cell Biology.

[49]  A. Gouw,et al.  Ductular reactions in human liver: Diversity at the interface , 2011, Hepatology.

[50]  Jeannie T. Lee,et al.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. , 2009, Cancer cell.